About VIB (104)
Bio imaging core (1)
Business opportunities (15)
Cardiovascular medicine (23)
Cell biology (11)
Developmental biology (6)
Inflammation and immunity (45)
International PhD Program (1)
Model Organisms (2)
Plant biology (87)
Research Areas (3)
Structural biology (22)
Systems biology (7)
About VIB (1)
Page Content Zone 1
Receive VIB press releases
Follow us on Twitter
Like us on Facebook
For all press inquiries, contact
Tel.: +32 9 244 66 11
Recent press releases
International recognition for Peter Carmeliet - VIB,KU Leuven - as influential biomedical scientist
6 November 2014
Peter Carmeliet's research has a significant impact, this has been confirmed by an international study who has placed Peter Carmeliet amongst the global top 400 most influential scientists in biomedical research.
Wake-up call for more research into cell metabolism
9 July 2014
New therapeutic avenues for diabetes, inflammatory conditions & cancer.
Understanding cell rearrangement during angiogenic sprouting
19 June 2014
Katie Bentley and Holger Gerhardt were able to demonstrate that differential dynamics of VE-cadherin junctions drive functional endothelial cell rearrangements during sprouting.
New target for the fight against cancer and diseases as a result of excessive blood vessel formation
1 August 2013
New blood vessel formation (angiogenesis) stimulates the growth of cancer and other diseases. Anti-angiogenic inhibitors slow down cancer growth by disrupting the blood supply to the tumor.
Discovery in Ghent could improve screening for sudden cardiac death
12 December 2012
Research by scientists from Ghent (VIB/UGent) and Italy will benefit compulsary screening methods for heart failure. They have discovered a link between mutations in a certain gene and the heart condition Arrhythmogenic Right Ventricular Cardiomyopathy.
Cell-VIB Symposium: Angiogenesis, Metabolic Regulation and Cancer Biology (July 6-8 2012, Leuven Belgium)
6 July 2012
VIB has teamed up with Cell for a symposium about angiogenesis, metabolic regulation and cancer biology, on July 6-8 2012 in Leuven, Belgium. Registration is now open.
Nanobodies can help prevent heart attacks
5 April 2012
Flemish scientists have succeeded, for the first time, in developing a technology that can distinguish between different types of arterial stenosis. Their discovery is an important step in the prevention of heart attacks and sudden death.
New strategy to accelerate blood vessel maturation has therapeutic potentials for ischemic diseases
10 October 2011
In Nature, VIB-K.U.Leuven researchers describe a new mechanism to enhance the restoration of the blood flow in ischemic diseases, which are among the leading causes of death worldwide.
Genetic basis of gynecological cancers
19 September 2010
Diether Lambrechts identified – in collaboration with several international teams – susceptibility loci for different gynecological cancers. Their findings resulted in three Nature Genetics papers.
Gene therapy for treating haemophilia working to correct the body’s blood clotting software
27 April 2010
VIB and Cellectis, the French genome engineering specialist, today announced that they are going to collaborate on research into new approaches to cure haemophilia.
Research on heart and vascular diseases earns Peter Carmeliet of VIB and K.U.Leuven the Ernst Jung Medical Award 2010
8 January 2010
His pioneering research on heart and vascular diseases and thrombosis has earned Peter Carmeliet the prestigious Ernst Jung Medical Award, one of the highest European prizes for biomedical research.
Septic shock, nitric oxide beneficial after all
15 December 2009
Scientists at VIB and Ghent University in Flanders, Belgium have found an unexpected ally for the treatment of septic shock, the major cause of death in intensive care units.
New strategy to combat cancer - Streamlining blood vessel walls
12 February 2009
Our blood vessels have a built-in rescue-mechanism that springs into action when there is insufficient oxygen in our tissues. VIB scientists at K.U.Leuven have now discovered that this mechanism can be mobilized in the battle against cancer.
Administering stem cells to patients with myocardial infarction leads to a reduction of the size of the infarct
9 January 2006
Scientists are publishing a major breakthrough in the treatment of patients with acute myocardial infarction
Tadpole soon to help in the fight against cancer and lymphedema
16 August 2005
Page Content Zone 2
Page Content Zone 3
Inflammation and immunity
Training and facilities
Int. Ph.D. Program